Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
Cryo-Cell International, Inc. last posted its earnings results on Tuesday, July 15th, 2025. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $-0.03 by $0.07. The company had revenue of 7.83 M for the quarter and had revenue of 31.99 M for the year. Cryo-Cell International, Inc. has generated $0 earnings per share over the last year ($0.05 diluted earnings per share) and currently has a price-to-earnings ratio of 69.57. Cryo-Cell International, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/15/2025 | Q3 2025 | N/A | $0.09 | N/A | $8.00 M | $7.83 M |
| 07/15/2025 | Q2 2025 | -$0.03 | $0.04 | 0.07 | $8.04 M | $7.93 M |
| 04/14/2025 | Q1 2025 | N/A | $0.03 | N/A | $7.88 M | $7.97 M |
| 02/28/2025 | Q4 2024 | $0.01 | -$0.23 | -0.24 | $7.99 M | $8.02 M |
| 10/17/2024 | Q3 2024 | N/A | $0.13 | N/A | $8.00 M | $8.07 M |
| 07/15/2024 | Q2 2024 | $0.04 | $0.08 | 0.04 | $8.00 M | $8.04 M |
| 04/15/2024 | Q1 2024 | -$0.00 | $0.07 | 0.07 | $7.90 M | $7.85 M |
| 02/28/2024 | Q4 2023 | -$0.07 | -$1.34 | -1.27 | $7.90 M | $7.88 M |
| 10/12/2023 | Q3 2023 | -$0.06 | $0.08 | 0.14 | N/A | $7.87 M |
| 07/14/2023 | Q2 2023 | -$0.08 | $0.03 | 0.11 | N/A | $7.77 M |
| 04/21/2023 | Q1 2023 | $0.02 | $0.09 | 0.07 | N/A | $7.82 M |
| 02/28/2023 | Q4 2022 | $0.01 | $0.10 | 0.08 | N/A | $7.76 M |
| 10/17/2022 | Q3 2022 | N/A | $0.06 | N/A | N/A | $7.68 M |
| 07/11/2022 | Q2 2022 | N/A | $0.08 | N/A | N/A | $7.63 M |
| 04/13/2022 | Q1 2022 | N/A | $0.10 | N/A | N/A | $7.26 M |
| 02/22/2022 | Q4 2021 | N/A | -$0.08 | N/A | N/A | $7.32 M |
| 10/15/2021 | Q3 2021 | N/A | $0.10 | N/A | N/A | $7.50 M |
| 07/15/2021 | Q2 2021 | N/A | $0.15 | N/A | N/A | $7.21 M |
| 04/14/2021 | Q1 2021 | N/A | $0.09 | N/A | N/A | $6.86 M |
| 03/01/2021 | Q4 2020 | N/A | $0.16 | N/A | N/A | $7.54 M |
In the previous quarter, Cryo-Cell International, Inc. (:CCEL) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.03 by $0.07.
The conference call for Cryo-Cell International, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Cryo-Cell International, Inc.'s latest earnings report can be read online.
Cryo-Cell International, Inc. (:CCEL) has a recorded annual revenue of $31.99 M.
Cryo-Cell International, Inc. (:CCEL) has a recorded net income of $402.10 K.Cryo-Cell International, Inc. has generated $0.05 earnings per share over the last four quarters.
Cryo-Cell International, Inc. (:CCEL) has a price-to-earnings ratio of 69.57 and price/earnings-to-growth ratio is -0.52.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED